PetrubAI
Pre-clinicalPerturbAI combines in vivo CRISPR and AI to accelerate drug discovery by mapping gene functions and disease mechanisms in living organisms.
Founded
2021
Focus
AI / Machine Learning
About
PerturbAI combines in vivo CRISPR and AI to accelerate drug discovery by mapping gene functions and disease mechanisms in living organisms.
Company Info
TypePrivate
Founded2021
LocationSan Francisco, United States
StagePre-clinical
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile